‍

Blake, Wm. The Vision of Christ. 1821.

‍

A revolutionary gene-editing treatment directly modifies patients’ DNA to fight genetic diseases, offering hope through less invasive procedures.

Unlike previous methods requiring cell extraction, this “in vivo” approach uses CRISPR technology for gene editing within the body, potentially simplifying and expanding access to treatments for complex conditions like cardiovascular disease.

In December, the U.S. endorsed the first CRISPR-based medicine for sickle-cell disease, signaling a leap forward in gene therapy’s application and the promise of in vivo editing to reach millions more patients.

Concerns linger over the risk of unintended gene modifications and the ethical implications of editing human DNA.